当前位置: X-MOL 学术New Genet. Soc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
‘Be ready against cancer, now’: direct-to-consumer advertising for genetic testing
New Genetics and Society ( IF 1.8 ) Pub Date : 2006-04-01 , DOI: 10.1080/14636770600603527
Bryn William-Jones 1
Affiliation  

Abstract A recent addition to the debate about the benefits and harms of direct-to-consumer (DTC) advertising of medicines and pharmaceuticals is a growing critique of DTC marketing and sale of genetic tests. Academic and policy literatures exploring this issue have, however, tended to focus on the sale of genetic tests, paying rather less attention to the particular implications of advertising. The globalization of broadcast media and ever increasing access to the Internet mean that public exposure to advertising for medical technologies is a reality that national regulatory bodies will be hard pressed to constrain. Working through a case study detailing Myriad Genetics' 2002 pilot advertising campaign for their BRACAnalysis genetic susceptibility test for hereditary breast and ovarian cancer, this paper highlights some of the diverse and often overlooked and unregulated approaches to DTC advertising, and the associated social, ethical and policy implications.

中文翻译:

“准备好对抗癌症,现在”:直接面向消费者的基因检测广告

摘要 关于药品和药品直接面向消费者 (DTC) 广告的好处和危害的辩论最近增加了对 DTC 营销和基因测试销售的越来越多的批评。然而,探讨这个问题的学术和政策文献倾向于关注基因测试的销售,而很少关注广告的特殊含义。广播媒体的全球化和互联网接入的不断增加意味着公众接触医疗技术广告是一个现实,国家监管机构将很难加以限制。通过案例研究,详细介绍了 Myriad Genetics 2002 年为其 BRACAnalysis 遗传性乳腺癌和卵巢癌遗传易感性测试进行的试点广告活动,
更新日期:2006-04-01
down
wechat
bug